Kruger Products' Q4 Results Watched Closely Amid Aggressive Expansion

MISSISSAUGA, Ontario – February 17, 2026 – The North American tissue market is poised for a significant data release as KP Tissue Inc. (TSX:KPT) prepares to unveil its fourth-quarter 2025 financial results, alongside those of its primary holding, Kruger Products Inc., before the market opens on February 18. The subsequent investor conference call is highly anticipated, with analysts and shareholders eager to dissect the performance of Canada's leading tissue manufacturer after a period of ambitious strategic investment and expansion.

The announcement serves as a critical barometer for a company navigating both opportunities in rising hygiene awareness and headwinds from volatile raw material markets. For KP Tissue, which holds a 12.1% equity interest in the manufacturing giant, the results will directly translate into its own valuation and shareholder outlook.

A Benchmark of Recent Performance

While the Q4 2025 figures remain under wraps, Kruger Products' recent financial history sets a strong, albeit complex, precedent. The company reported robust revenue of US$561.1 million in the third quarter of 2025, a 7.7% increase over the same period in the prior year. Adjusted EBITDA also showed impressive growth, climbing 30.4% to US$85.7 million. This top-line strength, however, was tempered by a decrease in net income, which was impacted by factors including foreign exchange fluctuations and increased costs associated with its significant expansion projects.

This pattern of strong revenue growth against a backdrop of heavy investment was also evident in its full-year 2024 results, where revenue grew 9.4% to surpass US$2 billion. Investors have taken note of this forward-looking strategy. Shares of KP Tissue (KPT) have shown resilience, recently touching a new 52-week high of C$10.55. Nonetheless, the analyst consensus remains a cautious "Hold," with average price targets hovering between C$10.25 and C$11.00, suggesting the market is in a "wait-and-see" mode, pending confirmation that these major capital outlays will translate into sustained profitability.

Doubling Down on North American Growth

The narrative for Kruger Products over the past year has been one of aggressive expansion and modernization. The company is not merely defending its market share; it is actively working to capture new territory, particularly in the high-value U.S. market. A cornerstone of this strategy was the June 2025 inauguration of its new LDC (light dry crepe) tissue plant in Sherbrooke, Quebec. The $377.5 million expansion effectively doubled the operational centre's production capacity to over 130,000 metric tonnes annually, a move designed to bolster its supply chain and meet growing demand.

Perhaps more significantly, the company announced bold plans in the third quarter of 2025 to construct a new, state-of-the-art tissue mill in the western United States. This facility will feature advanced through-air-dry (TAD) technology, positioning Kruger Products to compete directly in the ultra-premium tissue segment, a lucrative and growing part of the consumer market. With production slated to begin in 2028, the plant is expected to add another 75,000 metric tonnes of capacity. This was complemented by a further US$35 million investment in its Memphis facility to deploy a new converting line for bathroom tissue and paper towels, enhancing efficiency for its U.S. operations.

Navigating Broader Industry and Consumer Tides

Kruger Products' strategic maneuvers are set against the backdrop of a dynamic North American tissue paper market, which was valued at over USD 14 billion in 2025 and is projected to grow at a steady compound annual growth rate of 3.40% through 2033. This growth is fueled by heightened consumer focus on hygiene and personal care, trends that favor established brands like Cashmere®, Scotties®, and Purex®.

However, the industry is not without its challenges. Global pulp prices, a key cost component, experienced significant pressure and volatility in late 2025. Successfully managing these input costs is crucial for maintaining healthy margins. Simultaneously, consumer preferences are evolving, with sustainability emerging as a major purchasing driver. Kruger Products has proactively addressed this shift, earning recognition as Canada's Most Sustainable Brand in 2025 by Kantar BrandZ. The company's 2024 Sustainability Report outlined ambitious 2030 goals, including a 50% reduction in virgin plastic packaging, a 35% cut in greenhouse gas emissions, and the use of 100% third-party certified fibers across its ten FSC®-certified facilities. These initiatives, particularly highlighted by its eco-conscious Bonterra brand, align the company with modern consumer values and may provide a competitive edge.

The Investment Case for KP Tissue

For shareholders of KP Tissue, the company's unique structure makes Kruger Products' operational success paramount. As a holding entity, KPT's value is directly tied to the performance and long-term prospects of its 12.1% stake. The consistent quarterly dividend, most recently declared at $0.18 per share, signals a commitment to returning value to shareholders while the underlying asset executes its growth strategy.

Analysts project a significant long-term revenue growth rate for KP Tissue, reflecting the anticipated returns from Kruger Products' massive capital investments in Quebec, Memphis, and the upcoming U.S. mill. The company itself has signaled expectations that its Q4 2025 adjusted EBITDA would be similar to the strong results seen in Q3. As investors and market watchers tune into the conference call, they will be listening for confirmation of this stability and for management's outlook on market share growth, operational efficiency, and how these ambitious expansion projects are tracking against their financial and production targets. The forthcoming results will provide the first concrete data points of 2026, offering crucial insight into whether the company’s bold gambles are beginning to pay off.